Capital Impact Advisors’s Vascular Solutions Inc VASC Stock Holding History

Capital Impact Advisors’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-29,709	Closed	-$1.67M	–	249
2016 Q4	$1.67M	Hold	29,709	–	–	0.69%	20
2016 Q3	$1.43M	Hold	29,709	–	–	0.62%	34
2016 Q2	$1.24M	Hold	29,709	–	–	0.58%	37
2016 Q1	$966K	Buy	29,709 +2,550	+9%	+$73.5K	0.46%	71
2015 Q4	$934K	Hold	27,159	–	–	0.45%	76
2015 Q3	$880K	Hold	27,159	–	–	0.45%	71
2015 Q2	$943K	Hold	27,159	–	–	0.43%	74
2015 Q1	$823K	Buy	27,159 +19,522	+256%	+$561K	0.38%	101
2014 Q4	$207K	Hold	7,637	–	–	0.1%	113
2014 Q3	$189	Hold	7,637	–	–	﹤0.01%	103
2014 Q2	$169K	Buy	+7,637	New	+$167K	0.13%	140

Other funds holding VASC

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Capital Impact Advisors's VASC Position: Q1 2017 in Review

Capital Impact Advisors sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 29,709 shares — an estimated $1.67M sold.

Capital Impact Advisors first reported a position in VASC in Q2 2014 and held it in 11 quarters. The position peaked at $1.67M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

Capital Impact Advisors reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
Capital Impact Advisors sold 29,709 Vascular Solutions Inc shares in Q1 2017, an estimated $1.67M.
Capital Impact Advisors first reported a position in Vascular Solutions Inc in Q2 2014 and held it in 11 quarters.
Capital Impact Advisors's Vascular Solutions Inc position peaked at $1.67M in Q4 2016.
1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Capital Impact Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.